Washington University School of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).
Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.
Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.
Top-decile sponsor footprint
Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,502 total, page 22 of 31
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
NCT04623242
Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot Study
NCT01275339
Intravitreal Aflibercept Injection for Radiation Retinopathy
NCT01579760
Nitrous Oxide as Treatment for Major Depression - a Pilot Study
NCT02139540
Mommy-Baby Treatment for Perinatal Depression
NCT01744041
Eye Patch Therapy for Central Serous Retinopathy (CSR)
NCT02036632
3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery
NCT01964105
Off Clamp Randomization
NCT01732120
CYP2B6 Polymorphisms in Methadone Disposition
NCT01648283
Total vs. Reverse Shoulder Replacement: Pain Relief Two Years After Surgery
NCT01884077
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
NCT01661400
Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
NCT01744054
Neurofibromatosis Type 1 Brain Tumor Genetic Risk
NCT01707836
Weight Management in Obese Pregnant Underserved African American Women
NCT01768793
Nerve Transfer After Spinal Cord Injuries
NCT01714349
Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation
NCT01552694
Fatty Acid Radiotracer Comparison Study in Heart Failure Patients
NCT01648296
Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders
NCT01333098
Mechanisms of Immunosurveillance for Lung Cancer
NCT01710319
Geriatric Assessments in Senior Adults With Multiple Myeloma
NCT01746030
Calorie Restriction With Leucine Supplementation
NCT01757340
Comparative Ergonomic Analysis of Robotic Versus Laparoscopic Surgery
NCT01903577
Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation
NCT01653418
Vitamin D, Cardiovascular Disease, and African Americans
NCT01655810
Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer
NCT01566435
Efavirenz and Ritonavir on Human Brain P-Glycoprotein
NCT01668147
Treatment of Chronic Stroke With IpsiHand
NCT02552368
Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura
NCT01554514
The Effects of Ambrisentan on Exercise Capacity in Fontan Patients
NCT01971580
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
NCT01628523
Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
NCT02032030
Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma
NCT01555853
Systems Intervention to Promote Colorectal Cancer (CRC) Screening
NCT01299493
Use of Teach Back to Improve Comprehension of Discharge Instructions for Emergency Patients With Limited Health Literacy
NCT01968291
Patient Preferences of a Resect and Discard Paradigm
NCT02305251
Upper Extremity Surgery in Spinal Cord Injury
NCT01899664
Resistance Exercise in Barth Syndrome
NCT01629459
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
NCT01537861
Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT01246063
rTMS Bimodal Treatment For Tinnitus: A Pilot Study
NCT01590264
Duration of Brace Wear in Clubfoot Treatment - A Prospective Randomized Trial
NCT01551264
Healthy Eating and Active Living Taught at Home
NCT01567033
Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain
NCT01553916
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
NCT01525069
Promoting Smoking Cessation in Carpenters
NCT01878214
Buprenorphine Disposition and Cyclosporine
NCT01648270
Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant
NCT01390311
FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
NCT01413022
Study to Find the Dose of Rapidly Administered Ketamine for Brief Painful Procedures in Children
NCT01669642
Effective Communication to Improve Decision Making About Health Care Plans
NCT01986790
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 332 |
| Phase 2 | 237 |
| Phase 3 | 40 |
| Phase 4 | 58 |
Therapeutic Areas
What is open in the Washington University School of Medicine pipeline
214 recruiting of 1,502 indexed (14% open); 919 completed (61%).
Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).
Top condition: Obesity (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Washington University School of Medicine: open-pipeline peers nationwide
Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,502 trials (± recruiting share)
- Yale University · 1,492 trials · 17% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Washington University School of Medicine page
1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.
- 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.